Reveal Genomics launches new genomic test for HER2+ breast cancer
HER2DX offers accurate estimates of the risk of disease recurrence and the probability of therapy response to anti-HER2 drugs.

HER2DX offers accurate estimates of the risk of disease recurrence and the probability of therapy response to anti-HER2 drugs.
The project plans to develop new applications of PET in biomedical research and boost the sensitivity of devices.
BD to build a $200m drug delivery device manufacturing facility in Zaragoza, Spain.
Graphene Flagship spin-off INBRAIN has raised over €14m in a Series A funding round for its intelligent graphene-based neural implants…
ByScientists from Israeli company MeMed and the Rabin Medical Center in Israel have demonstrated that a rapid test could identify…
UK-based Creo Medical Group has announced the acquisition of Albyn Medical, a Spain-based manufacturer of gastroenterology, urology and endoscopy products,…
Medical device specialist Rods&Cones and technology company Iristick have worked together to develop a pair of smart glasses which allow…
ByBarcelona-based medical device company Anaconda Biomed has raised €20m in a funding round, with plans to use the proceeds for…